Cart
sales@molnova.com
Pelubiprofen
CAS No. 69956-77-0
Pelubiprofen( —— )
Catalog No. M33458 CAS No. 69956-77-0
Pelubiprofen is an orally active, non-steroidal anti-inflammatory agent, a selective cyclooxygenase-2 (COX-2) inhibitor, which effectively reduces PGE(2) production by inhibiting COX activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 222 | In Stock |
|
| 100MG | 352 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 821 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePelubiprofen
-
NoteResearch use only, not for human use.
-
Brief DescriptionPelubiprofen is an orally active, non-steroidal anti-inflammatory agent, a selective cyclooxygenase-2 (COX-2) inhibitor, which effectively reduces PGE(2) production by inhibiting COX activity.
-
DescriptionPelubiprofen, an orally active and non-steroidal anti-inflammatory drug, is a member of the 2-arylpropionic acid family and has relatively selective effects on COX-2 activity. Pelubiprofen inhibits COX activity and the transforming growth factor-β activated kinase 1-IκB kinase β-NF-κB pathway, and has significant anti-inflammatory and analgesic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number69956-77-0
-
Formula Weight258.31
-
Molecular FormulaC16H18O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (387.13 mM; Ultrasonic )
-
SMILESC(\C1=CC=C(C(C(O)=O)C)C=C1)=C\2/C(=O)CCCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Choi IA, Baek HJ, et al. Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial. BMC Musculoskelet Disord. 2014 Nov 18;15:375.?
molnova catalog
related products
-
Roflumilast N-oxide
Roflumilast N-oxide is a PDE type 4 inhibitor.
-
TFAP
TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor.
-
Tenoxicam
Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.
